Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
6 hedge funds and large institutions have $594K invested in Counterpath Corp in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
19% less capital invested
Capital invested by funds: $736K → $594K (-$142K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.34K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$624 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$457 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$119 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$31K |
CPAH Hedge Fund Activity: Q3 2018 in Review
6 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q3 2018, worth a combined $594K — down 19% from $736K a quarter earlier.
Fund positioning in CPAH was balanced in Q3 2018: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $4.34K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $31K sold.
- 6 institutional investors held Counterpath Corp (CPAH) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $594K of Counterpath Corp stock for Q3 2018, down 19% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q3 2018 and 1 closed out, a net change of 0 holders.
- The largest Counterpath Corp buyer in Q3 2018 was UBS Group, an estimated $4.34K added.
- The largest Counterpath Corp seller in Q3 2018 was Acadian Asset Management, an estimated $31K sold.
Based on aggregated 13F filings for Q3 2018.